Tissue Regenix Group Plc (TRX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 28,646 | 29,493 | 24,476 | 19,746 | 17,484 |
| Cost of Goods | 15,025 | 15,453 | 13,218 | 11,270 | 9,448 |
| Gross Profit | 13,621 | 14,040 | 11,258 | 8,476 | 8,035 |
| Operating Expenses | 13,148 | 14,434 | 13,268 | 12,574 | 13,718 |
| Operating Income | 473 | -394 | -2,010 | -4,098 | -5,683 |
| Interest Expense | 882 | 890 | 741 | 692 | 606 |
| Other Income | -155 | -385 | -77 | -352 | -7,667 |
| Pre-tax Income | -564 | -1,669 | -2,828 | -5,142 | -13,957 |
| Income Tax | 289 | -12 | -232 | -157 | -726 |
| Net Income Continuous | -853 | -1,657 | -2,596 | -4,985 | -13,230 |
| Net Income Discontinuous | 172 | N/A | N/A | N/A | N/A |
| Minority Interests | -32 | -56 | -99 | 193 | -1 |
| Net Income | $-713 | $-1,713 | $-2,695 | $-4,792 | $-13,232 |
| EPS Basic Total Ops | -0.01 | -0.02 | -0.04 | -0.07 | -0.30 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.04 | -0.07 | -0.30 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.04 | -0.07 | -0.30 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.04 | -0.07 | -0.30 |
| EBITDA(a) | $1,364 | $198 | $-952 | $-3,359 | $-12,312 |